Masaya Ueno1,2, Atsushi Hirao1,2 (1.Cancer Research Institute, Kanazawa University, Japan, 2.WPI Nano Life Science Institute, Kanazawa University, Japan)
Session information
Oral Session
Oral Session 1-13C CML: Basic
Fri. Oct 12, 2018 3:10 PM - 4:10 PM No.13 (Osaka International Convention Center, 11F 1101-2)
Chair: Kazuhito Naka (Department of Stem Cell Biology, Research Institute for Rediation Biology and Medicine, Hiroshima University, Japan)
Tetsuzo Tauchi, Seiichi Okabe, Seiichiro Katagiri, Yuko Tanaka, Kazuma Ohyashiki (Hematol., Tokyo Med. Univ., Tokyo, Japan)
Yotaro Ochi1,2, Kenichi Yoshida1, Ying-Jung Huang3, Ming-Chung Kuo3,4, Yusuke Shiozawa1, Yasuhito Nannya1, Yuichi Shiraishi5, Hiroko Tanaka5, Kenichi Chiba5, Satoru Miyano5, Akifumi Takaori-Kondo2, Lee-Yung Shih3,4, Seishi Ogawa1 (1.Pathol and Tumor Biol, Kyoto Univ., Kyoto, Japan, 2.Hematol and Oncol, Kyoto Univ., Kyoto, Japan, 3.Hemat-Oncol, Chang Gung Memor Hosp, Taoyuan, Taiwan, 4.College of Medicine, Chang Gung Univ, Taoyuan, Taiwan, 5.Lab of DNA Information Analysis, Tokyo Univ, Tokyo, Japan)
Jun Toda1, Michiko Ichii1, Hideaki Saito1, Yuichi Kitai2, Ryuta Muromoto2, Jun-Ichi Kashiwakura2, Kodai Saitoh2, Hirohiko Shibayama1, Tadashi Matsuda2, Kenji Oritani3, Yuzuru Kanakura1 (1.Hematology and Oncology, Osaka University, Osaka, Japan, 2.Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan, 3.Hematology, International University of Health and Welfare, Chiba, Japan)
Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, Kazuma Ohyashiki (Dept. of Hematol, Tokyo Med. Univ., Tokyo, Japan)
Toshimi Hoshiko1, Yasushi Kubota1,2, Satomi Nakagawara3, Takuya Akizawa3, Tatsuro Watanabe4, Kazuaki Tanigawara3, Jyunichi Yano3, Shinya Kimura1,4 (1.Hematol & Oncol., Saga Univ., Saga, Japan, 2.Transfusion Med., Saga Univ Hosp., Saga, Japan, 3.Rena Therapeutics Inc., Tokyo, Japan, 4.Drug Discov. and Biomed. Sci., Saga Univ., Saga, Japan)